| Literature DB >> 28503647 |
Parveen Chagani1, Yasmin Parpio1, Raisa Gul1, Adnan A Jabbar2.
Abstract
OBJECTIVE: Cancer is a leading cause of death worldwide. Likewise, in Pakistan, it is a major health problem, with an approximate increase each year. Cancer treatment, particularly chemotherapy, produces a detrimental effect on individuals' well-being. Since the past few years, quality of life (QOL) is considered as the primary goal of cancer treatment in patients' survival. This study aimed to assess the QOL and its determinants in adult cancer patients undergoing chemotherapy treatment.Entities:
Keywords: Cancer; chemotherapy; emotional well-being; physical well-being; quality of life; social well-being
Year: 2017 PMID: 28503647 PMCID: PMC5412152 DOI: 10.4103/2347-5625.204499
Source DB: PubMed Journal: Asia Pac J Oncol Nurs ISSN: 2347-5625
Demographic profile of the adult cancer patients
| Characteristics | |
|---|---|
| Gender | |
| Male | 51 (34.0) |
| Female | 99 (66.0) |
| Age (years) | |
| 19-35 | 30 (20.0) |
| 36-50 | 52 (34.7) |
| 51-65 | 56 (37.3) |
| >65 | 12 (8.0) |
| Marital status | |
| Married | 124 (82.7) |
| Unmarried | 24 (16.0) |
| Separated/divorced/widowed | 2 (1.3) |
| Educational status | |
| Below primary | 10 (6.7) |
| Primary | 11 (7.3) |
| Matric | 18 (12.0) |
| Intermediate | 30 (30.0) |
| Graduation and above | 81 (54.0) |
| Occupational status | |
| Employed | 39 (26.0) |
| Unemployed | 111 (74.0) |
| Earning members | |
| 1 | 114 (76.0) |
| 2 | 28 (18.7) |
| >2 | 7 (4.70) |
| Monthly income | |
| >20,000 | 11 (7.3) |
| 21,000-50,000 | 91 (60.7) |
| 51,000-100,000 | 41 (27.3) |
| >100,000 | 6 (4.0) |
| Financing of chemotherapy cost | |
| Self-financed | 124 (82.7) |
| Sponsored | 19 (12.7) |
| Donors | 7 (4.7) |
Values are n (%)
Clinical characteristics and therapeutics of adult cancer patient
| Characteristics | |
|---|---|
| Cancer type | |
| Breast | 43 (28.7) |
| Ovarian | 29 (19.3) |
| Colon/rectum | 23 (15.3) |
| Head and neck | 6 (4.0) |
| Others | 49 (32.7) |
| Disease stage | |
| I | 1 (0.7) |
| II | 17 (11.3) |
| III | 63 (42.0) |
| IV | 64 (42.7) |
| Type of chemotherapy | |
| Neo-adjuvant | 40 (26.7) |
| Adjuvant | 47 (31.3) |
| Palliative | 63 (42.0) |
| Number of chemotherapy sessions received | |
| 2-5 | 84 (56.0) |
| 6-10 | 45 (30.0) |
| 11-15 | 17 (11.3) |
| >15 | 4 (2.70) |
| Duration of postchemotherapy side effects | |
| 2-3 days | 47 (31.3) |
| 1 week | 63 (42.0) |
| >1 week | 40 (26.7) |
| Hospitalization | |
| Yes | 34 (22.7) |
| No | 116 (77.3) |
| Information received | |
| Yes | 134 (89.3) |
| No | 16 (10.7) |
Values are n (%)
Quality of life scores in all four domains of the functional assessment of cancer therapy-general tool
| Domains | Minimum | Maximum | Mean | SD | |
|---|---|---|---|---|---|
| Physical well-being | 150 | 2 | 24 | 10.41 | 5.321 |
| Social/family well-being | 150 | 11 | 27 | 22.33 | 3.422 |
| Emotional well-being | 150 | 2 | 23 | 10.32 | 4.954 |
| Functional well-being | 150 | 5 | 25 | 14.31 | 4.227 |
| Overall QOL | 150 | 29 | 92 | 57.37 | 13.11 |
P=0.05 is significant, QOL: Quality of life, SD: Standard deviation
Multivariable analysis of determinants associated with quality of life
| Characteristics | β (SE [β]) | 95% CI | |
|---|---|---|---|
| Female | −1.51 (0.594) | −2.69-−0.34 | 0.012 |
| Unemployed | −1.34 (0.619) | −2.56-−0.11 | 0.032 |
| Chemotherapy side effects (>1 week) | −1.186 (0.589) | −2.3-−0.020 | 0.046 |
| No hospitalization | 1.435 (0.548) | 0.340-2.52 | 0.010 |
| Parents (as caretaker) | −1.620 (0.742) | −3.08-−0.15 | 0.031 |
| No significant change | 1.56 (0.619) | 0.342-2.79 | 0.013 |
| No socialization | −2.256 (0.523) | −3.29-−1.22 | <0.001 |
| Discrimination by family/relatives | −8.535 (1.984) | −12.45-4.61 | 0.000 |
FACT-G: Functional assessment of cancer therapy-general, QOL: Quality of life, CI: Confidence interval, SE: Standard error